Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...
Has your skin ever felt a little more irritable than usual? If you ever had itchy, red or flaky patches that look ...
More patients treated with Vtama achieved vIGA-AD success compared with those who received vehicle cream in both ADORING 1 (45% vs 14%) and ADORING 2 (46% vs 18%). The Food and Drug Administration ...
The FDA has approved Organon’s Vtama (tapinarof) cream, 1%, for the treatment of atopic dermatitis (AD) in adults and children as young as two years of age. According to the company, the approval was ...
“With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with ...
The scalp is a very common area for seborrheic dermatitis because it produces a ... Some at-home treatments for ringworm like antifungal sprays, creams, or powders can be enough to treat minor tinea ...
The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis. Ahead of its extended target action date of March 12, 2025, the FDA approved ...
“With the FDA’s approval of VTAMA cream in atopic dermatitis for adults and children as young as 2 years old, there is now a therapy that offers the potential for powerful skin clearance with no label ...
There are seven different types of eczema, including three that can cause rashes on your eyelids: contact dermatitis, atopic dermatitis, and seborrheic dermatitis ... are both commonly treated with ...
Symptoms include: Seborrheic dermatitis commonly affects areas that produce oil or where hair grows. These are areas that secrete sebum (oil). This dermatitis has a scaly, dry appearance and may ...
Opens in a new tab or window Tapinarof 1% topical cream showed greater efficacy than the control in adults and children as young as age 2 years with atopic dermatitis (AD). The cream also provided ...